In a murine model of PD, pre-treatment with BCP prevented (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) MPTP-induced neurotoxic injury of dopaminergic neurons, resulting in a significant inhibition of SNpc neuron loss and suppression of the autochthonal microglia and astrocytes, thereby reducing the release of pro-inflammatory cytokines within the surrounding tissues [279]. This evidence concerns the gene OPN1SW and Parkinson disease.